WFG Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$226K Buy
3,197
+953
+42% +$63.4K 0.05% 343
2017
Q1
$152K Sell
2,244
-608
-21% -$42.8K 0.04% 392
2016
Q4
$204K Buy
2,852
+72
+3% +$5.35K 0.05% 375
2016
Q3
$220K Buy
2,780
+269
+11% +$21.9K 0.05% 344
2016
Q2
$209K Sell
2,511
-978
-28% -$86.8K 0.06% 327
2016
Q1
$321K Sell
3,489
-10
-0.3% -$902 0.09% 219
2015
Q4
$354K Buy
3,499
+316
+10% +$32.9K 0.11% 203
2015
Q3
$313K Sell
3,183
-2,380
-43% -$264K 0.1% 208
2015
Q2
$651K Sell
5,563
-525
-9% -$57.4K 0.18% 127
2015
Q1
$597K Buy
6,088
+2,539
+72% +$258K 0.17% 139
2014
Q4
$335K Buy
3,549
+2,529
+248% +$262K 0.07% 314
2014
Q3
$109K Buy
1,020
+59
+6% +$5.78K 0.02% 634
2014
Q2
$80K Sell
961
-254
-21% -$19.8K 0.01% 733
2014
Q1
$86K Sell
1,215
-7,937
-87% -$622K 0.02% 693
2013
Q4
$687K Sell
9,152
-465
-5% -$32.4K 0.1% 239
2013
Q3
$605K Sell
9,617
-2,172
-18% -$130K 0.09% 245
2013
Q2
$604K Buy
+11,789
New +$614K 0.1% 231

Other funds holding GILD

WFG Advisors's GILD Position: Q2 2017 in Review

WFG Advisors increased its Gilead Sciences (GILD) stake by 42% in Q2 2017, buying an estimated $63.4K and bringing the position to 3,197 shares worth $226K. The position accounts for 0.05% of the portfolio, ranked #343.

WFG Advisors first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. The position peaked at $687K in Q4 2013. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • WFG Advisors held 3,197 shares of Gilead Sciences worth $226K as of Q2 2017.
  • WFG Advisors bought 953 Gilead Sciences shares in Q2 2017, an estimated $63.4K.
  • Gilead Sciences made up 0.05% of WFG Advisors's portfolio in Q2 2017, its #343 holding.
  • WFG Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
  • WFG Advisors's Gilead Sciences position peaked at $687K in Q4 2013.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.